1. GBD 2017 Oral Disorders Collaborators. Bernabe E, Marcenes W, Hernandez CR et al (2020) Global, Regional, and National Levels and Trends in Burden of Oral Conditions from 1990 to 2017: A Systematic Analysis for the Global Burden of Disease 2017 Study. J Dent Res 99(4):362-373. doi: 10.1177/0022034520908533.
2. Houshmand M, Holtfreter B, Berg MH et al (2012) Refining definitions of periodontal disease and caries for prediction models of incident tooth loss. J Clin Periodontol 39(7):635-44. doi: 10.1111/j.1600-051X.2012.01892.x.
3. Haag DG, Peres KG, Balasubramanian M et al (2017) Oral Conditions and Health-Related Quality of Life: A Systematic Review. J Dent Res 96(8):864-874. doi:10.1177/0022034517709737
4. Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 71(3):209-249. doi: 10.3322/caac.21660.
5. Harbeck N, Gnant M (2017) Breast cancer. Lancet 389(10074):1134-1150. doi:10.1016/S0140-6736(16)31891-8
6. Brinton LA, Gaudet MM, Gierach GL (2018) Breast cancer, Cancer Epidemiology and Prevention p. 861‐888.
7. Łukasiewicz S, Czeczelewski M, Forma A et al (2021) Breast Cancer-Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies-An Updated Review. Cancers (Basel) 13(17):4287. doi: 10.3390/cancers13174287.
8. Runowicz CD, Leach CR, Henry NL et al (2016) American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. CA Cancer J Clin 66(1):43-73. doi:10.3322/caac.21319
9. Epstein JB, Thariat J, Bensadoun RJ et al (2012) Oral complications of cancer and cancer therapy: from cancer treatment to survivorship. CA Cancer J Clin 62(6):400-422. doi:10.3322/caac.21157
10. Jardim LC, Flores PT, de Araujo Sensever F et al (2019) Oral lesions and associated factors in breast cancer survivors. J Investig Clin Dent 10(4):e12447. doi:10.1111/jicd.12447
11. Jardim LC, Flores PT, do Carmo Dos Santos Araújo M et al (2020) Oral health-related quality of life in breast cancer survivors. Support Care Cancer 28(1):65-71. doi: 10.1007/s00520-019-04792-3.
12. Ustaoğlu G, Bulut DG, Üyetürk U et al (2021) Evaluation of periodontal health in breast cancer patients undergoing tamoxifen or aromatase inhibitors drugs therapy: A cross-sectional study. Spec Care Dentist Jan;41(1):41-48.
13. Hong CH, Napeñas JJ, Hodgson BD et al (2010) A systematic review of dental disease in patients undergoing cancer therapy. Support Care Cancer 18(8):1007-1021. doi:10.1007/s00520-010-0873-2
14. Taichman LS, Van Poznak CH, Inglehart MR (2016) Self-reported oral health and quality of life of postmenopausal breast cancer survivors on aromatase inhibitors and women without cancer diagnoses: a longitudinal analysis. Support Care Cancer 24(11):4815-4824. doi:10.1007/s00520-016-3336-6
15. Amódio J, Palioto DB, Carrara HH et al (2014) Oral health after breast cancer treatment in postmenopausal women. Clinics 69(10):706-708. doi:10.6061/clinics/2014(10)10
16. World Health Organization (1997) Oral Health Surveys. Basic Methods. Geneva: World Health Organization :93.
17. Nowjack-Raymer RE, Sheiham A (2007) Numbers of natural teeth, diet, and nutritional status in US adults. J Dent Res 86(12):1171-1175. doi:10.1177/154405910708601206
18. Chen QL, Zeng XT, Luo ZX et al (2016)Tooth loss is associated with increased risk of esophageal cancer: evidence from a meta-analysis with dose-response analysis. Sci Rep 6:18900. Published 2016 Jan 8. doi:10.1038/srep18900
19. Shi J, Leng W, Zhao L et al (2017) Tooth loss and cancer risk: a dose-response meta analysis of prospective cohort studies. Oncotarget 9(19):15090-15100. Published 2017 Dec 16. doi:10.18632/oncotarget.23850
20. Loos BG (2005) Systemic markers of inflammation in periodontitis. J Periodontol 76(11 Suppl):2106-2115. doi:10.1902/jop.2005.76.11-S.2106
21. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420(6917):860-867. doi:10.1038/nature01322
22. Zhang HP, Cao HY, Yuan AH (2013) The principle and progress of anti‐inflammation treatment of gastric cancer. Modern Medical Journal 41(8), 605– 609.
23. Shi T, Min M, Sun C et al (2018) Periodontal disease and susceptibility to breast cancer: A meta-analysis of observational studies. J Clin Periodontol 45(9):1025-1033. doi:10.1111/jcpe.12982
24. Waks AG, Winer EP (2019) Breast Cancer Treatment: A Review. JAMA 321(3):288-300. doi:10.1001/jama.2018.19323
25. Davies C, Pan H, Godwin J et al (2013) Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial [published correction appears in Lancet Mar 9;381(9869):804. doi: 10.1016/S0140-6736(12)61963-1.
26. Mahesh DR, Komali G, Jayanthi K et al (2014) Evaluation of Salivary Flow Rate, pH and Buffer in Pre, Post & Post Menopausal Women on HRT. J Clin Diagn Res Feb;8(2):233-6. doi: 10.7860/JCDR/2014/8158.4067.
27. Taichman LS, Havens AM, Van Poznak CH (2013) Potential implications of adjuvant endocrine therapy for the oral health of postmenopausal women with breast cancer. Breast Cancer Res Treat 137(1):23-32. doi:10.1007/s10549-012-2217-z
28. Taichman LS, Gomez G, Inglehart MR (2015) Oral Health-Related Complications of Breast Cancer Treatment: Assessing Dental Hygienists' Knowledge and Professional Practice. J Dent Hyg 89 Suppl 2(Suppl 2):22-37.
29. Pedersen AML, Sørensen CE, Proctor GB (2018) Salivary secretion in health and disease. J Oral Rehabil 45(9):730-746.
30. Välimaa H, Savolainen S, Soukka T (2004) Estrogen receptor-beta is the predominant estrogen receptor subtype in human oral epithelium and salivary glands. J Endocrinol Jan;180(1):55-62. doi: 10.1677/joe.0.1800055.
31. Lucisano MP, da Silva RAB, de Sousa Pereira AP (2021) Alteration of the oral microbiota may be a responsible factor, along with estrogen deficiency, by the development of larger periapical lesions. Clin Oral Investig Jun;25(6):3651-3662. doi: 10.1007/s00784-020-03688-5.
32. Streckfus CF, Baur U, Brown LJ et al (1998) Effects of estrogen status and aging on salivary flow rates in healthy Caucasian women. Gerontology 44(1):32-39. doi:10.1159/000021980
33. Mosel DD, Bauer RL, Lynch DP et al (2011) Oral complications in the treatment of cancer patients. Oral Dis 17(6):550-559. doi:10.1111/j.1601-0825.2011.01788.x
34. Kim S, Park S, Lin M (2017) Permanent tooth loss and sugar-sweetened beverage intake in U.S. young adults. J Public Health Dent 77(2):148-154. doi:10.1111/jphd.12192
35. Matos DL, Lima-Costa MF, Guerra HL (2002) Bambuí Project: an evaluation of private, public and unionized dental services. Rev Saude Publica 36(2):237-243. doi:10.1590/s0034-89102002000200017
36. Unfer B, Saliba O (2000) Evaluate of popular knowledge and everyday practices in oral health. Rev Saude Publica 34(2):190-195. doi:10.1590/s0034-89102000000200014
37. Srivastava P, Chen G, Harris A (2017) Oral Health, Dental Insurance and Dental Service use in Australia. Health Econ 26(1):35-53. doi:10.1002/hec.3272